The expression levels of S100A8 or the heterodimer, S100A8/A9, are increased in tumor cells in multiple types of cancer, including gastric (8), colon (9) and pancreatic cancer (8), but rarely in RCC. Here, S100A8 is linked to renal cell carcinoma.